Axim Planning & Wealth Acquires New Shares in Colgate-Palmolive Company $CL

Axim Planning & Wealth bought a new position in Colgate-Palmolive Company (NYSE:CL) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 6,959 shares of the company’s stock, valued at approximately $556,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Ironwood Investment Counsel LLC increased its holdings in Colgate-Palmolive by 6.6% in the 3rd quarter. Ironwood Investment Counsel LLC now owns 6,923 shares of the company’s stock worth $553,000 after buying an additional 427 shares in the last quarter. Concord Wealth Partners boosted its holdings in shares of Colgate-Palmolive by 13.8% during the 3rd quarter. Concord Wealth Partners now owns 16,512 shares of the company’s stock valued at $1,320,000 after acquiring an additional 2,008 shares during the last quarter. HORAN Wealth LLC bought a new stake in shares of Colgate-Palmolive in the third quarter worth approximately $344,000. Bessemer Group Inc. raised its holdings in shares of Colgate-Palmolive by 17.6% during the third quarter. Bessemer Group Inc. now owns 22,651 shares of the company’s stock valued at $1,811,000 after purchasing an additional 3,387 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its position in Colgate-Palmolive by 61.4% during the third quarter. BI Asset Management Fondsmaeglerselskab A S now owns 499,621 shares of the company’s stock valued at $39,940,000 after purchasing an additional 190,114 shares during the period. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Stock Down 0.4%

NYSE CL opened at $94.48 on Friday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90. The company has a market capitalization of $76.16 billion, a P/E ratio of 36.06, a price-to-earnings-growth ratio of 4.29 and a beta of 0.29. The stock’s 50-day moving average price is $82.13 and its 200-day moving average price is $81.65.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same period in the prior year, the firm posted $0.91 EPS. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be issued a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.2%. Colgate-Palmolive’s dividend payout ratio is currently 79.39%.

Insider Transactions at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the sale, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.34% of the company’s stock.

Wall Street Analysts Forecast Growth

CL has been the subject of a number of research analyst reports. Bank of America lifted their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Citigroup upped their price objective on Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday. The Goldman Sachs Group reissued a “buy” rating and issued a $94.00 target price on shares of Colgate-Palmolive in a research report on Saturday, January 31st. TD Cowen reaffirmed a “buy” rating on shares of Colgate-Palmolive in a research report on Monday. Finally, Argus reissued a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Eleven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.47.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.